Talk:2022 Nobel Prize in Physiology or Medicine

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Nominees[edit]

The lists featured in the article are the physicians and medical experts speculated to possibly win the Nobel Prize in Physiology or Medicine based on verified news agencies. Such lists are quite appropriate side by side with the official list of nominees to be revealed after 50 years, in observing predictions, and speculating deliberations and nominations. The list will be used in analysing who were the favourite physiologists and medicals doctors to win a specific year and the shortlisted individuals by the Karolinska Institute's Nobel Committee, and as to who were among the officially nominated or favoured to win despite not being nominated. The article will be a good reference for analysts and observers of the Nobel Prizes. For example, I have also created similar lists from 2020 to 2021 Nobel Prize in Physiology or Medicine. Therefore, do not remove the lists. JB Hoang Tam (talk) 23:58, 7 October 2022 (UTC)[reply]

If this section is to stay, I strongly suggest converting it to prose. Presenting it in a table form misguides the readers that this is the "official" list of candidates, as typical in other award articles. --Tone 14:35, 9 October 2022 (UTC)[reply]

Possible Nominees[edit]

The following section is requested to be deleted from the article:

Possible nominees[edit]

Breast cancer discoveries and mRNA vaccines were seen as possible winners for the 2022 prize.[1][2] Among the most favoured contenders by numerous medical institutes were the following medical researchers and physiologists:

Unofficial candidates for the 2022 Nobel Prize in Physiology or Medicine
Nominee Country Motivation Institute(s)
Pieter Cullis
(b. 1946)
 Canada "for his pioneering contribution to lipid nanoparticle packaging of the mRNA."[3] University of British Columbia
Katalin Karikó
(b. 1955)
 Hungary
 United States
"for developing modified RNA technology which enabled rapid production of effective COVID-19 vaccines."[3][4][5] BioNTech
University of Pennsylvania
Drew Weissman
(b. 1958)
 United States University of Pennsylvania
Robert S. Langer
(b. 1948)
 United States "for his discoveries leading to the development of controlled drug-release systems and new biomaterials."[5] Massachusetts Institute of Technology
Uğur Şahin
(b. 1965)
 Germany "for the development of RNA vaccines to induce antigen-specific tolerance in autoimmune diseases and against the COVID-19 virus."[5] BioNTech
Özlem Türeci
(b. 1967)
 Germany
Sarah Gilbert
(b. 1962)
 United Kingdom "for the development of viral vectored vaccines that work by inducing strong and protective T and B cell responses."[5] University of Oxford
Nahum Sonenberg
(b. 1946)
 Israel
 Canada
"for their pioneer mRNA research in the development of Moderna's mRNA vaccine."[3] McGill University
Derrick Rossi
(b. 1966)
 Canada University of Toronto
Noubar Afeyan
(b. 1962)
 United States
 Canada
McGill University
Marilyn Gaston
(b. 1939)
 United States "for her leading researches on the sickle cell disease, an inherited condition in which the body is unable to produce normal hemoglobin."[4] Health Resources and Services Administration
Masato Hasegawa
(b. 1961)
 Japan "for the identification of TDP-43, a pathological signature of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), and for other contributions to the study of neurodegenerative diseases."[6][5] Tokyo Metropolitan Institute of Medical Science
Virginia Man-Yee Lee (b. 1945)  China
 United States
University of Pennsylvania
Mary-Claire King
(b. 1946)
 United States "for demonstrating inherited susceptibility for breast and ovarian cancer and discovering the role played by mutations of the BRCA1 gene."[4][6][5] University of Washington
Michael Stratton
(b. 1957)
 United Kingdom "for their contributions to the genetics of human cancer, mapping and isolating the breast cancer susceptibility gene BRCA2 and other cancer predisposition genes, CYLD and STK11."[5] Wellcome Trust Sanger Institute
Institute of Cancer Research
Richard Wooster
(b. 1964)
 United Kingdom Institute of Cancer Research
Stuart Orkin
(b. 1946)
 United States "for his foundational research on the genetic basis of blood diseases and for advancing gene therapy for sickle cell anemia and beta-thalassemia."[6] Harvard Medical School
Howard Hughes Medical Institute
George Demetri
(b. 1959)
 United States "for his contributions to epigenetic therapies against tumors, especially those that lack the SMARCB1 gene."[5] Harvard Medical School
Dennis Yuk Ming Lo
(b. 1963)
 Hong Kong "for his pioneering development of noninvasive prenatal testing and novel methods of detecting cancer liquid biopsies."[1] The Chinese University of Hong Kong
Axel Ullrich
(b. 1943)
 Germany "for their research, which led to the development of the breast cancer drug Herceptin."[1] Max Planck Institute of Biochemistry
Dennis Slamon
(b. 1948)
 United States Jonsson Comprehensive Cancer Center

JB Hoang Tam (talk) 08:30, 14 October 2022 (UTC) [reply]

References

  1. ^ a b c "Medicine prize opens Nobel week clouded by war". The Japan Times. 3 October 2022. Retrieved 3 October 2022.
  2. ^ Marc Preel and Alma Cohen (3 October 2022). "Medicine Prize opens Nobel week clouded by war". Phys.org. Archived from the original on 3 October 2022. Retrieved 3 October 2022.
  3. ^ a b c John Bergeron (22 September 2022). "Canadian scientists lead Nobel Prize medicine race for developing mRNA vaccine". The Economic Times. Archived from the original on 4 October 2022. Retrieved 27 September 2022.
  4. ^ a b c Katie Hunt (30 September 2022). "5 women who should have won a Nobel Prize". CNN. Archived from the original on 30 September 2022. Retrieved 1 October 2022.
  5. ^ a b c d e f g h David Armstrong (2 October 2022). "2022 Nobel Prize Predictions – The Science of the Francis Mule". Award World. Archived from the original on 4 October 2022. Retrieved 3 October 2022.
  6. ^ a b c "Clarivate Reveals Citation Laureates 2022 – Annual List of Researchers of Nobel Class". Clarivate. 21 September 2022. Archived from the original on 21 September 2022. Retrieved 21 September 2022.

More detailed explanation of the work[edit]

I feel like this page would be infinitely more meaningful if it included a few paragraphs at least on the history of the work and, more importantly, a general background of the findings and their significance in warranting a Nobel.


Philologick (talk) 01:34, 3 October 2023 (UTC)[reply]